What will be required by us once

New Post Public Reply Private Reply Replies (1) Message Board
picon
What will be required by us once licensed.:



Documents

147.1 A licensed producer must keep
(a) for each request received from a licensing authority under subsection 102(1), (i) a copy of the request, together with any supporting documentation received,
(ii) a record of the date on which the request and documentation were received,
(iii) a copy of the information that was provided in response to the request,
(iv) a record of the date on which the information was provided, and
(v) a record of the steps that were taken to ensure that the information was securely transmitted to the authority;

(b) a copy of any request or notice received from a licensing authority under section 102.1 and a record of the date on which it was received;
(c) for each instance in which they provide information to a licensing authority under section 102.1, (i) a copy of the information,
(ii) a record of the date on which the information was provided, and
(iii) a record of the steps that were taken to ensure that the information was securely transmitted to the authority; and

(d) in any case where there is no information to provide to a licensing authority for a period referred to in subsection 102.1(3), a copy of the notice sent under subsection 102.1(4).

5. (1) Paragraphs 148(2)(a) and (b) of the French version of the Regulations are replaced by the following:
a) s’agissant de tout avis écrit qu’il doit envoyer dans le cadre du présent règlement, pour une période de deux ans suivant son envoi;
b) s’agissant des renseignements qu’il doit consigner conformément aux articles 134 et 137, au paragraphe 138(1), à l’article 139, aux paragraphes 140(1) et 141(1) et aux articles 144 et 146, pour une période de deux ans suivant le jour de leur consignation;

(2) Subsection 148(2) of the Regulations is amended by striking out “and” at the end of paragraph (k) and by adding the following after paragraph (l):
(m) in the case of a document or record referred to in paragraph 147.1(a), for a period of two years after the day on which the information was provided to the licensing authority;
(n) in the case of a request or notice referred to in paragraph 147.1(b), for a period of two years after the day on which it was received;
(o) in the case of a document or record referred to in paragraph 147.1(c), for a period of two years after the day by which the producer was required to provide the information; and
(p) in the case of a notice referred to in paragraph 147.1(d), for a period of two years after the end of the period to which the notice relates.

6. Section 253 of the Regulations is replaced by the following:

Definitions

253. (1) For the purpose of sections 256 to 266, “authorization to possess”, “designated-person production licence”, “medical practitioner” and “personal-use production licence” have the same meaning as in subsection 1(1) of the Marihuana Medical Access Regulations.

Medical declaration

(2) For the purpose of sections 256 and 259, “medical declaration” means a medical declaration that was made by a medical practitioner in accordance with sections 6 and 8 of the Marihuana Medical Access Regulations.

7. Section 254 of the Regulations is replaced by the following:

Applicable period

254. Section 255 applies until March 31, 2015.

8. Sections 254 and 255 of the Regulations are repealed.

9. (1) The portion of section 256 of the Regulations before paragraph (a) is replaced by the following:

Modified application of Regulations

256. If a registration application under section 108 was made in accordance with section 255 on or before March 31, 2015, the provisions of these Regulations, other than section 129, apply with the following modifications:

(2) Paragraph 256(a) of the Regulations is amended by adding the following after subparagraph (i):
(i.1) paragraph 102(2)(a),
(i.2) subsection 102.1(1),

10. Sections 257 to 259 of the Regulations are replaced by the following:

Modified application of Regulations

259. If a registration application under section 108 was made in accordance with section 258 on or before March 31, 2014, the provisions of these Regulations, other than paragraph 110(a) and section 129, apply with the following modifications:
(a) a reference in sections 1 to 150 to a “medical document” is to be read as a reference to a medical declaration, except in the case of (i) the definition “medical document” in subsection 1(1),
(ii) paragraph 102(2)(a),
(iii) subsection 102.1(1),
(iv) paragraph 128(1)(b), and
(v) a provision referred to in paragraph (b); and

(b) a provision that is referred to in column 1 of the table to this section is to be read as set out in column 2.

TABLE




Item

Column 1

Provision

Column 2

Modified text

1. paragraph 5(a) (a) in the case of dried marihuana obtained from a licensed producer in accordance with a medical declaration, 30 times the daily amount specified in the medical declaration;

2. subparagraph 67(a)(ii) (ii) the name of the medical practitioner who made the client’s medical declaration,

3. section 112 112. (1) A client’s registration expires at the earlier of (a) the day that is one year after the day on which the medical declaration supporting the registration was signed by the medical practitioner, and
(b) if applicable, the day on which the period of usage specified in the medical declaration expires.

(2) For the purpose of paragraph (1)(b), the period of usage begins on the day on which the medical declaration was signed by the medical practitioner.
4. paragraphs 113(d) to (f) (d) more than one year has elapsed since the day on which the medical declaration submitted with the application was signed by the medical practitioner;
(d.1) if applicable, the period of usage specified in the medical declaration has expired, with that period being deemed to have commenced on the day on which the medical declaration was signed by the medical practitioner;
(e) the name or date of birth of the applicant is different from the name or date of birth that appears on the medical declaration;
(f) the medical practitioner who made the medical declaration informs the licensed producer in writing that the use of dried marihuana by the applicant is no longer supported for clinical reasons; or

5. subsection 124(1) (1) A licensed producer must not sell or provide to a client or an individual who is responsible for the client in any 30-day period a total quantity of dried marihuana that exceeds 30 times the daily amount specified in the medical declaration supporting the client’s registration.

11. The Regulations are amended by adding the following after section 259.3:

Licensing Authorities

Additional information — earlier registrations

259.4 (1) A licensing authority that submits — on or before the day that is six months after the day on which this section comes into force — a request under subsection 102.1(1) may indicate in the request that it wishes to receive, in addition to the information referred to in subsection 102.1(2), the same information in respect of any earlier registrations.

Obligation to provide information

(2) If a licensed producer receives a request that has been submitted in accordance with subsection (1), they must provide the licensing authority with the additional information, if any, when they first provide information to the authority under section 102.1. The producer must also comply with the requirements of subsection 102.1(7) in respect of the information.

Recordkeeping requirements

(3) The licensed producer must comply with the requirements of the following provisions in respect of information provided under subsection (2):
(a) paragraph 147.1(c);
(b) subsection 148(1);
(c) paragraph 148(2)(o); and
(d) section 149.

Notice

(4) If the licensed producer has no additional information to provide, they must
(a) send a notice of that fact to the licensing authority;
(b) keep a copy of the notice for two years; and
(c) comply with the requirements of subsection 148(1) and section 149 in respect of the notice.

Former licensed producers

(5) If the licensed producer’s licence expires without being renewed or is revoked, the former licensed producer must comply with the requirements of paragraph 148(1)(a), paragraph 148(2)(o) and section 149 in respect of any information that was provided before the licence expired or was revoked.

COMING INTO FORCE

12. (1) Subject to subsections (2) and (3), these Regulations come into force on the day on which they are registered.

(2) Section 8 comes into force on March 31, 2015.

(3) Section 6 and subsection 9(1) come into force on April 1, 2015.

[24-1-o]
Footnote a
S.C. 1996, c. 19
Footnote 1
C.R.C., c. 1041
Footnote 2
SOR/2013-119
Date modified:2014-06-14



Secondary menu




Publications



Part Ⅰ: Notices and Proposed Regulations


Vol. 148 (2014)


ARCHIVED — Vol. 147 (2013)


ARCHIVED — Vol. 146 (2012)


ARCHIVED — Vol. 145 (2011)


ARCHIVED — Vol. 144 (2010)


ARCHIVED — Vol. 143 (2009)


ARCHIVED — Vol. 142 (2008)




Part Ⅰ: Quarterly Index


Vol. 148 (2014)


ARCHIVED — Vol. 147 (2013)


ARCHIVED — Vol. 146 (2012)


ARCHIVED — Vol. 145 (2011)


ARCHIVED — Vol. 144 (2010)


ARCHIVED — Vol. 143 (2009)


ARCHIVED — Vol. 142 (2008)




Part Ⅱ: Official Regulations

























Part Ⅱ: Consolidated Index

























Part Ⅲ: Acts of Parliament






















Archives







Latest Publications

Creative Edge Nutrition Inc. (FITX) Stock Research Links

FITX Board Company Profile Buy Rating Time & Sales News Filings Financials
In times when you feel low self esteem, disappointment and perhaps even depression.......keep in mind that it may simply be the result of the fact that you are surrounded by ass holes. GLTA
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 5

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 5

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading

Top 5 Most Recently Viewed Articles

Red Pine Unveils Exciting Gold Discoveries at Wawa Project

Updated Category News Views 177

Red Pine Exploration's Impressive Drilling Results Red Pine Exploration Inc. (TSXV: RPX, OTCQB: RDEXF) is thrilled to announce outstanding results from its ongoing drilling program at the Wawa Gold Project. This Canadian gold exploration company has executed a comprehensive drilling initiative, totaling 2,793 meters across three drill holes, aiming to unlock the full...

Continue Reading
Silver's Backwardation: What It Means for Investors Today

Updated Category News Views 447

Understanding Silver's Current Market Dynamics Recently, silver's futures market revealed a significant shift, entering a state of backwardation not seen for four decades. This phenomenon indicates that the short-term contract price is considerably higher than longer-term futures, reflecting a dramatic demand for immediate physical silver. The difference of $2.88...

Continue Reading
PGIM High Yield Funds Announce Monthly Distributions

Updated Category News Views 508

PGIM Funds Unveil Distribution Plans for Shareholders NEWARK, N.J.--PGIM High Yield Bond Fund, Inc. (NYSE: ISD), PGIM Global High Yield Fund, Inc. (NYSE: GHY), and PGIM Short Duration High Yield Opportunities Fund (NYSE: SDHY) have announced their monthly distributions for December 2024, January, and February 2025. This initiative signifies their commitment to delivering...

Continue Reading
Investors Urged to Act as Altimmune Faces Legal Challenges

Updated Category News Views 156

Important Legal Investigations Concerning Altimmune, Inc. Faruqi & Faruqi, LLP is currently investigating potential claims on behalf of investors who may have suffered financial losses related to Altimmune, Inc. (NASDAQ: ALT). Investors who acquired securities of Altimmune should pay close attention to this matter, as there are critical developments that could affect...

Continue Reading
Conejo Valley Unified Faces Lawsuits Over Assault Inaction

Updated Category News Views 6

Legal Scrutiny Hits Conejo Valley Unified In what feels like a never-ending cycle of educational mishaps, Conejo Valley Unified School District and its Westlake High School find themselves under the harsh spotlight of the legal system. Two lawsuits filed in Ventura County Superior Court are laying bare some serious accusations against them. Former students, using the...

Continue Reading